Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193216 · ClinicalTrials.gov registry record · Phase 2
The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus
A Phase 2 study of Barretts Esophagus With Dysplasia, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03193216 is a Phase 2 study of Barretts Esophagus With Dysplasia that has completed, run by Medical University of South Carolina. The registered enrollment target is 24 participants, below the 706-participant average among 5 other Barretts Esophagus With Dysplasia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03193216, a Phase 2 study of Barretts Esophagus With Dysplasia, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the addition of an alginate based solution to twice daily proton pump inhibitor therapy (PPI) in patients undergoing ablative therapy for dysplastic Barrett's esophagus. The investigators hypothesize that the addition of this medication will help to achieve complete remission of Barrett's over a shorter period of time.
Conditions Studied
Interventions
- DRUG Alginates
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-08-25 |
| Est. Completion | 2022-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03193216
The ClinicalTrials.gov registry entry for NCT03193216 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 706-participant average among 5 other Barretts Esophagus With Dysplasia trials with a reported enrollment target (97% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barretts Esophagus With Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which Alginates is the first listed.
NCT03193216 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT03193216 about?
NCT03193216 is a clinical study titled "The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus". This study evaluates the addition of an alginate based solution to twice daily proton pump inhibitor therapy (PPI) in patients undergoing ablative therapy for dysplastic Barrett's esophagus. The investigators hypothesize that the addition of this medication will help to achieve complete remission of...
What is the current status of trial NCT03193216?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2017-08-25. Estimated completion is 2022-01-01.
What conditions does trial NCT03193216 study?
This clinical trial studies the following conditions: Barretts Esophagus With Dysplasia.
What interventions are being tested in trial NCT03193216?
The interventions under investigation include: Alginates (DRUG).
Who is sponsoring clinical trial NCT03193216?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03193216 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barretts Esophagus With Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
-
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
RECRUITING · NA
-
Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
ACTIVE NOT RECRUITING
-
Characterization of the Neo-squamous Epithelial Barrier
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.